Franklin Genomic Advancements ETF
HELX
HELX
11 hedge funds and large institutions have $7.53M invested in Franklin Genomic Advancements ETF in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
118.4% less ownership
Funds ownership: 273.6% → 155.21% (-118%)
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$5.54M | |
| 2 | +$238K | |
| 3 | +$62K | |
| 4 |
SWM
Spire Wealth Management
Mclean,
Virginia
|
+$38.6K |
| 5 |
BFEC
Benjamin F. Edwards & Company
St. Louis,
Missouri
|
+$13.6K |
Top Sellers
| 1 | -$7.29M | |
| 2 | -$4.24M | |
| 3 | -$464K | |
| 4 |
HI
Harbour Investments
Madison,
Wisconsin
|
-$156K |
| 5 |
APA
American Portfolios Advisors
Holbrook,
New York
|
-$14K |